                         SEQUENCE LISTING

<110>  CHILDREN'S HOSPITAL LOS ANGELES
       WU, Lingtao
 
<120>  COMPOSITIONS AND METHODS FOR TREATING LEUKEMIA

<130>  65474-006WO0

<150>  61/548,628
<151>  2011-10-18

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  1281
<212>  DNA
<213>  Homo sapiens

<400>  1
cgcgcttccg agagtctgta ggagggaaac cgccatggac gatcagggtt gccctcggtg       60

taagaccacc aaatatcgga acccctcctt gaagctgatg gtgaatgtgt gcggacacac      120

tctctgtgaa agttgtgtag atttactgtt tgtgagagga gctggaaact gccctgagtg      180

tggtactcca ctcagaaaga gcaacttcag ggtacaactc tttgaagatc ccactgttga      240

caaggaggtt gagatcagga aaaaagtgct aaagatatac aataaaaggg aagaagattt      300

tcctagtcta agagaataca atgatttctt ggaagaagtg gaagaaattg ttttcaactt      360

gaccaacaat gtggatttgg acaacaccaa aaagaaaatg gagatatacc aaaaggaaaa      420

caaagatgtt attcagaaaa ataaattaaa gctgactcga gaacaggaag aactggaaga      480

agctttagaa gtggaacgac aggaaaatga acaaagaaga ttatttatac aaaaagaaga      540

acaactgcag cagattctaa aaaggaagaa taagcaggct tttttagatg agctggagag      600

ttctgatctc cctgttgctc tgcttttggc tcagcataaa gatagatcta cccaattaga      660

aatgcaactt gagaaaccca aacctgtaaa accagtgacg ttttccacag gcatcaaaat      720

gggtcaacat atttcactgg cacctattca caagcttgaa gaagctctgt atgaatacca      780

gccactgcag atagagacat atggaccaca tgttcctgag cttgagatgc taggaagact      840

tgggtattta aaccatgtca gagctgcctc accacaggac cttgctggag gctatacttc      900

ttctcttgct tgtcacagag cactacagga tgcattcagt gggcttttct ggcagcccag      960

ttaaccattt ataagatttg gaccttggag ctgaaccagg gagctagcaa aagtaaagca     1020

gacttataaa attatagcta tgtgcagctg cacaacacag tccttccact agcagctgtg     1080

ttaaagtatt tataaggaga aaatttcaga actaagttga gtaatatagg ggatatatat     1140

ttgtgaaaaa taatttttac ttatattttt cagaggattt gacacgataa gcctcatctg     1200

atggaagaga ggaataaata attcacctat atgtgtttga ggttgtgaca gacttataaa     1260

atcttttaaa aaataaagct g                                               1281


<210>  2
<211>  309
<212>  PRT
<213>  Homo sapiens

<400>  2

Met Asp Asp Gln Gly Cys Pro Arg Cys Lys Thr Thr Lys Tyr Arg Asn 
1               5                   10                  15      


Pro Ser Leu Lys Leu Met Val Asn Val Cys Gly His Thr Leu Cys Glu 
            20                  25                  30          


Ser Cys Val Asp Leu Leu Phe Val Arg Gly Ala Gly Asn Cys Pro Glu 
        35                  40                  45              


Cys Gly Thr Pro Leu Arg Lys Ser Asn Phe Arg Val Gln Leu Phe Glu 
    50                  55                  60                  


Asp Pro Thr Val Asp Lys Glu Val Glu Ile Arg Lys Lys Val Leu Lys 
65                  70                  75                  80  


Ile Tyr Asn Lys Arg Glu Glu Asp Phe Pro Ser Leu Arg Glu Tyr Asn 
                85                  90                  95      


Asp Phe Leu Glu Glu Val Glu Glu Ile Val Phe Asn Leu Thr Asn Asn 
            100                 105                 110         


Val Asp Leu Asp Asn Thr Lys Lys Lys Met Glu Ile Tyr Gln Lys Glu 
        115                 120                 125             


Asn Lys Asp Val Ile Gln Lys Asn Lys Leu Lys Leu Thr Arg Glu Gln 
    130                 135                 140                 


Glu Glu Leu Glu Glu Ala Leu Glu Val Glu Arg Gln Glu Asn Glu Gln 
145                 150                 155                 160 


Arg Arg Leu Phe Ile Gln Lys Glu Glu Gln Leu Gln Gln Ile Leu Lys 
                165                 170                 175     


Arg Lys Asn Lys Gln Ala Phe Leu Asp Glu Leu Glu Ser Ser Asp Leu 
            180                 185                 190         


Pro Val Ala Leu Leu Leu Ala Gln His Lys Asp Arg Ser Thr Gln Leu 
        195                 200                 205             


Glu Met Gln Leu Glu Lys Pro Lys Pro Val Lys Pro Val Thr Phe Ser 
    210                 215                 220                 


Thr Gly Ile Lys Met Gly Gln His Ile Ser Leu Ala Pro Ile His Lys 
225                 230                 235                 240 


Leu Glu Glu Ala Leu Tyr Glu Tyr Gln Pro Leu Gln Ile Glu Thr Tyr 
                245                 250                 255     


Gly Pro His Val Pro Glu Leu Glu Met Leu Gly Arg Leu Gly Tyr Leu 
            260                 265                 270         


Asn His Val Arg Ala Ala Ser Pro Gln Asp Leu Ala Gly Gly Tyr Thr 
        275                 280                 285             


Ser Ser Leu Ala Cys His Arg Ala Leu Gln Asp Ala Phe Ser Gly Leu 
    290                 295                 300                 


Phe Trp Gln Pro Ser 
305                 


<210>  3
<211>  246
<212>  DNA
<213>  Homo sapiens

<400>  3
atgggtcaac atatttcact ggcacctatt cacaagcttg aagaagctct gtatgaatac       60

cagccactgc agatagagac atatggacca catgttcctg agcttgagat gctaggaaga      120

cttgggtatt taaaccatgt cagagctgcc tcaccacagg accttgctgg aggctatact      180

tcttctcttg cttgtcacag agcactacag gatgcattca gtgggctttt ctggcagccc      240

agttaa                                                                 246


<210>  4
<211>  81
<212>  PRT
<213>  Homo sapiens

<400>  4

Met Gly Gln His Ile Ser Leu Ala Pro Ile His Lys Leu Glu Glu Ala 
1               5                   10                  15      


Leu Tyr Glu Tyr Gln Pro Leu Gln Ile Glu Thr Tyr Gly Pro His Val 
            20                  25                  30          


Pro Glu Leu Glu Met Leu Gly Arg Leu Gly Tyr Leu Asn His Val Arg 
        35                  40                  45              


Ala Ala Ser Pro Gln Asp Leu Ala Gly Gly Tyr Thr Ser Ser Leu Ala 
    50                  55                  60                  


Cys His Arg Ala Leu Gln Asp Ala Phe Ser Gly Leu Phe Trp Gln Pro 
65                  70                  75                  80  


Ser 
    


<210>  5
<211>  65
<212>  DNA
<213>  Homo sapiens

<400>  5
cccgaattca ccaccatgga ctacaaggac gacgatgaca agatgggtca acatatttca       60

ctggc                                                                   65


<210>  6
<211>  42
<212>  DNA
<213>  Homo sapiens

<400>  6
cccggatcca ctgggctgcc agaaaagccc actgaatgca tc                          42


